358 related articles for article (PubMed ID: 36556962)
1. Gut-Lung Microbiota Interaction in COPD Patients: A Literature Review.
Krumina A; Bogdanova M; Gintere S; Viksna L
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556962
[TBL] [Abstract][Full Text] [Related]
2. Imbalance of gut microbiota is involved in the development of chronic obstructive pulmonary disease: A review.
Song W; Yue Y; Zhang Q
Biomed Pharmacother; 2023 Sep; 165():115150. PubMed ID: 37429232
[TBL] [Abstract][Full Text] [Related]
3. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
4. The Bidirectional Gut-Lung Axis in Chronic Obstructive Pulmonary Disease.
Wang L; Cai Y; Garssen J; Henricks PAJ; Folkerts G; Braber S
Am J Respir Crit Care Med; 2023 May; 207(9):1145-1160. PubMed ID: 36883945
[TBL] [Abstract][Full Text] [Related]
5. The treatment of Qibai Pingfei Capsule on chronic obstructive pulmonary disease may be mediated by Th17/Treg balance and gut-lung axis microbiota.
Jia Y; He T; Wu D; Tong J; Zhu J; Li Z; Dong J
J Transl Med; 2022 Jun; 20(1):281. PubMed ID: 35729584
[TBL] [Abstract][Full Text] [Related]
6. Role of Short-Chain Fatty Acids Produced by Gut Microbiota in Innate Lung Immunity and Pathogenesis of the Heterogeneous Course of Chronic Obstructive Pulmonary Disease.
Kotlyarov S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563159
[TBL] [Abstract][Full Text] [Related]
7. Lung microbiome, gut-lung axis and chronic obstructive pulmonary disease.
Gokulan K; Joshi M; Khare S; Bartter T
Curr Opin Pulm Med; 2022 Mar; 28(2):134-138. PubMed ID: 34907959
[TBL] [Abstract][Full Text] [Related]
8. The Bufei Jianpi Formula Improves Mucosal Immune Function by Remodeling Gut Microbiota Through the SCFAs/GPR43/NLRP3 Pathway in Chronic Obstructive Pulmonary Disease Rats.
Mao J; Li Y; Bian Q; Xuan Y; Li J; Wang Z; Feng S; Liu X; Tian Y; Li S
Int J Chron Obstruct Pulmon Dis; 2022; 17():1285-1298. PubMed ID: 35673595
[TBL] [Abstract][Full Text] [Related]
9. Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study.
Chiu YC; Lee SW; Liu CW; Lan TY; Wu LS
Respir Res; 2022 Jan; 23(1):10. PubMed ID: 35033061
[TBL] [Abstract][Full Text] [Related]
10. The Gut Microbiota and Respiratory Diseases: New Evidence.
Chunxi L; Haiyue L; Yanxia L; Jianbing P; Jin S
J Immunol Res; 2020; 2020():2340670. PubMed ID: 32802893
[TBL] [Abstract][Full Text] [Related]
11. Gut-lung Microbiota Interactions in Chronic Obstructive Pulmonary Disease (COPD): Potential Mechanisms Driving Progression to COPD and Epidemiological Data.
De Nuccio F; Piscitelli P; Toraldo DM
Lung; 2022 Dec; 200(6):773-781. PubMed ID: 36241745
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota: A new insight into lung diseases.
Ma PJ; Wang MM; Wang Y
Biomed Pharmacother; 2022 Nov; 155():113810. PubMed ID: 36271581
[TBL] [Abstract][Full Text] [Related]
13. When smoke meets gut: deciphering the interactions between tobacco smoking and gut microbiota in disease development.
Chen B; Zeng G; Sun L; Jiang C
Sci China Life Sci; 2024 May; 67(5):854-864. PubMed ID: 38265598
[TBL] [Abstract][Full Text] [Related]
14. The association between the respiratory tract microbiome and clinical outcomes in patients with COPD.
Yu S; Zhang H; Wan L; Xue M; Zhang Y; Gao X
Microbiol Res; 2023 Jan; 266():127244. PubMed ID: 36335803
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between the lung microbiome and lung cancer.
Meng Y; Mao Y; Tang Z; Qiu X; Bajinka O; Tan Y; Song Z
Microb Pathog; 2023 May; 178():106062. PubMed ID: 36914054
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota, in the Halfway between Nutrition and Lung Function.
Espírito Santo C; Caseiro C; Martins MJ; Monteiro R; Brandão I
Nutrients; 2021 May; 13(5):. PubMed ID: 34069415
[TBL] [Abstract][Full Text] [Related]
17. Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease.
Liu J; Ran Z; Wang F; Xin C; Xiong B; Song Z
Crit Rev Microbiol; 2021 Feb; 47(1):1-12. PubMed ID: 33040638
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota and Lung Injury.
Tan JY; Tang YC; Huang J
Adv Exp Med Biol; 2020; 1238():55-72. PubMed ID: 32323180
[TBL] [Abstract][Full Text] [Related]
19. Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease.
Kayongo A; Robertson NM; Siddharthan T; Ntayi ML; Ndawula JC; Sande OJ; Bagaya BS; Kirenga B; Mayanja-Kizza H; Joloba ML; Forslund SK
Front Immunol; 2022; 13():1085551. PubMed ID: 36741369
[TBL] [Abstract][Full Text] [Related]
20. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations.
Sun Z; Zhu QL; Shen Y; Yan T; Zhou X
Kaohsiung J Med Sci; 2020 Feb; 36(2):107-113. PubMed ID: 31782610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
